Specific antibody plaque-forming cells (PFC) to Shigella-soluble antigen did not appear in spleen cell cultures from Shigella-tolerant mice, as occurred with similar cultures prepared from normal mice immunized with Shigella antigen prior to sacrifice. Cultures from tolerant mice also failed to form serologically detectable amounts of agglutinins in vitro. Exposure of cell cultures from tolerant mice in vitro to additional antigen had little or no effect on appearance of plaque-forming cells to Shigella. Spleen cells from normal control mice formed readily detectable levels of antibody, as well as specific antibody plaque-forming cells, after similar stimulation with antigen either in vivo or in vitro. The absence of antibody-forming cells in cultures prepared from spleens of tolerant mice was specific since such cultures, as well as those from normal control mice, formed numerous antibody plaques to unsensitized sheep erythrocytes in vitro after in vivo challenge of the mice with sheep erythrocytes. Tolerance to Shigella antigen, as assessed by absence of antibodyforming cells in vitro, persisted for several months. Spleen cell cultures from tolerant mice less than 3 to 4 months of age did not form significant numbers of antibody plaques, even after in vitro exposure to specific antigen. However, spleen cultures prepared from neonatally treated mice, approximately 6 to 8 months old, formed essentially normal numbers of specific PFC in vitro, indicating that the animals had "recovered" from tolerance and that their lymphoid cells were capable of responding to Shigella antigen in vitro. Absence of specific PFC in cell cultures from tolerant animals supports the concept that tolerance is due to a central failure of specific immunocompetent cells and not due to an inhibitory effect caused by either "excess" antigen or humoral antibody.
Specific immunologic tolerance or paralysis to a variety of antigens such as serum proteins, simple chemical haptens, foreign erythrocytes, or microbial products is considered to be related to a central failure of antibody formation (13, 20, 22) . Results of previous studies in our laboratory indicated that mice injected at birth with a relatively large inoculum of somatic antigens derived from Shigella paradysenteriae become tolerant so that subsequent injection later in life with Shigella antigen fails to elicit a typical agglutinin response, as occurs in normal, nontolerant mice (3, 5, 10) . Such (8, 16 ). An indirect antibody plaque technique was utilized previously to detect and localize specific antibody-secreting cells in lymphoid tissues of Shigella-tolerant and normal mice (9) . No evidence was obtained that significant numbers of antibody-forming cells to Shigella could appear in spleens of tolerant animals after challenge immunization.
In a different approach, lymphoid cells from Shigella-tolerant mice have been transferred to normal and X-irradiated recipients, followed by challenge immunization with specific antigen (3, 6) . Whereas spleen cells from normal mice transferred specific agglutinin-forming ability, similar cell suspensions from tolerant mice were ineffective. "Adoptive" tolerance was readily demonstrated in X-irradiated recipient mice injected with spleen or lymph node cells from tolerant donors, suggesting that the transferred cell population lacked specific immunocompetent cells (6) . In additional studies, maintenance of lymphoid cells from tolerant mice in tissue culture medium under conditions in which cells from normal mice readily formed detectable agglutinins failed to result in significant antibody formation (7) . The results of these experiments suggested that the lymphoid cell populations from animals tolerant to Shigella antigens could not "escape" from tolerance in vitro.
In these experiments, a similar approach was used, with the addition that the antibody plaque technique was utilized as a sensitive indicator of specific antibody-forming cells in vitro. Spleen cell suspensions from either normal or Shigellatolerant mice were incubated in tissue culture medium in vitro, and the number of specific plaque-forming cells (PFC) to Shigella was enumerated at various time intervals thereafter.
METHODS AND MATERIALS
Experimental animals. National Institutes of Health albino A mice were used for these experiments as described previously (8) (9) (10) . They were obtained from a single colony of mice bred and maintained by a local dealer.
Antigens. Shigella-soluble antigen, referred to as SSA, was prepared by trypsin digestion of alcoholkilled suspensions of S. paradysenteriae and was used both for induction of tolerance and for in vivo challenge immunization, as described previously (3, (5) (6) (7) (8) (9) (10) . For in vitro challenge, 1 to 10 jug of antigen was incubated with spleen cell suspensions from either tolerant or control mice for 2 hr at 37 C, followed by centrifugation and washed twice with cold, sterile medium to remove soluble antigen. In a number of control experiments, both Shigella-tolerant and normal adult mice were challenged by intraperitoneal injection of 0.5 ml of a 20% suspension of washed sheep erythrocytes (S-RBC).
Antibody titrations. Serum samples were obtained from control and experimental mice by retro-orbital puncture prior to and at close periodic intervals after challenge injection with antigen. Serial twofold dilutions were prepared with physiological saline solution, pH 7.2, in microtiter plates in a volume of 0.025 ml, as described previously (7, 9) . In addition, supernatant fluids of tissue culture suspensions were also tested for antibody (7) . Specific antigen, either alcohol-killed Shigella, or washed sheep erythrocytes, was added to each dilution cup, as described in other investigations (7) (8) (9) . In additional tests, sheep erythrocytes sensitized with SSA were also used (9) . In these instances, serological inhibition tests were performed to demonstrate the specificity of the positive hemagglutinin reactions.
In vitro culture technique. Spleens were obtained aseptically from experimental and control mice immediately after sacrifice by cervical dislocation. Cell suspensions were prepared by "teasing" the spleens in sterile medium 199 (Hanks' base, pH 7.2), containing penicillin and streptomycin (100,ug of each per ml). The cells were washed twice by serial centrifugation in the cold with sterile medium. Viability was estimated by trypan blue-staining technique, and total cell counts were determined with a hemocytometer. The cells were resuspended to 10% by volume in sterile medium. An 0.5-ml of a suspension, with approximately 20 X 106 nucleated cells, was added to 1 or 2 ml of medium containing 20% isologous sterile mouse or fetal calf serum free of serologically detectable Shigella agglutinins. Plastic tissue culture tubes, 18 by 150 mm, were used for each culture and were placed in a slowly rotating drum in an incubator at 37 C with an atmosphere of 95% oxygen and 5% CO2 (7) . At least 10 cultures were prepared at a time from a single pool of cells. Prior to incubation and at various time intervals thereafter, 0.1-ml portions were removed from each tube, in duplicate, for determination of the number of antibody PFC. In addition, the medium was usually changed at periodic intervals by gently centrifuging the culture tube and decanting. The supernatant fluids were tested for antibody.
Hemolytic plaque assay. The direct immunoplaque assay for detection of localized zones of hemolysis with uncoated erythrocytes was performed essentially as described previously (4, 9, 12) . In brief, 0.1 ml of a suspension of dispersed spleen cells, either obtained directly from an animal or from tissue culture tubes, was mixed with 2.0 ml of warm, melted 0.7% Noble agar (Difco), to which had been added 1.0 ml of diethylaminoethyl-dextran and 0.1 ml of a 10% suspension of sheep erythrocytes. This mixture was carefully layered onto the surface of a previously prepared 100-mm diameter plastic petri plate, containing 15 ml of solidified 1.4% Noble agar in Hanks' solution. Following solidification of the agar (red blood cell-leukocyte mixture), the plates were incubated at 37 C for 1 hr and then treated with 5 to 10 ml of a 1: 15 dilution of guinea pig serum as a source of complement. After further incubation for 30 min at 37 C, zones of hemolysis appeared (antibody plaques). The plaques were made more distinct, and the plates were preserved for extended periods of time by staining with a solution of benzidine, hydrogen peroxide, and acetic acid (12) . The number of antibody PFC per plate was enumerated, and the number FRIEDMAN of PFC per million leukocytes or per culture tube was calculated.
For the indirect or passive antibody plaque technique, sheep erythrocytes treated with Shigella antigen were used in place of the untreated red cells, as described previously (9) . Washed sheep erythrocytes were incubated for 1 hr at 37 C with I to 2 pg of SSA and then washed several times with saline. The resulting sensitized sheep erythrocytes were used exactly as for the direct plaque procedure. When relatively few plaques were expected with spleen cell suspensions or cultures from tolerant animals, relatively large numbers of cells were used for plating in attempts to obtain counts within the range of 50 to 200 hemolytic zones per plate. In those instances, there were often apparently nonspecific hemolytic areas, probably due to the debris in the suspensions or to aggregated cells. The cell suspensions in these cases were always washed several additional times with saline and filtered through fine gauze. In addition, extra plates were poured in duplicate and not treated with complement, but stained with benzidine. The number of hemolytic zones in these complementfree plates was subtracted from the number of plaques counted in plates treated with guinea pig serum (9 (Fig. 1) Agglutinin titers of culture supernatant fluids from control mice generally ranged from 1:8 to 1:64. There was usually no agglutinin titer greater than 1 :4 or 1 :8 in culture supernatant fluids from spleens of tolerant mice between 4 and 6 months of age (Table 3) .
Specificity of unresponsiveness in vitro. Groups of normal and Shigella-tolerant mice were challenged at 3 to 4 months of age with an immunizing inoculum of either SSA or sheep erythrocytes. The animals were sacrificed 4 to 5 days later, and spleen cell suspensions were prepared for culture. SSA was added to one set of tubes. Sheep erythrocytes were added to a second set of tubes, and a third set was treated with both SSA and red blood cells. After 2 hr of incubation, the cell suspensions were washed and resuspended in fresh medium. There were varying numbers of PFC to SSA-or to untreated sheep erythrocytes in the various cultures (Table 4) . Spleen cell cultures from nontolerant mice challenged in vivo with SSA had many PFC to Shigella, even without in vitro exposure to the antigen. The number of PFC was usually higher when these cultures were treated with SSA. Spleen cells from other control mice immunized with sheep red blood cells alone formed but few PFC to SSA. However, the number of PFC to SSA was often higher in these cultures when treated in vitro with SSA than when treated with sheep erythrocytes alone.
There was little or no PFC response to Shigella by spleen cell cultures from tolerant mice which were either untreated or injected in vivo with either SSA or S-RBC. Additional exposure of the cultures in vitro to SSA had no effect. The PFC response to RBC alone was essentially the same for spleen cell cultures from either tolerant or normal mice immunized in vivo with RBC. For example, cultures prepared from Shigella-tolerant mice immunized in vivo with red blood cells and treated in vitro with SSA alone had approximately 175 hemolysin-forming cells per million leukocytes, whereas similar cultures from normal mice immunized with RBC had about 150 PFC per 106 leukocytes. When sheep erythrocytes were added in vitro to such cultures, the PFC response to red blood cells increased to about the same level of 450 or 475 PFC per culture. When these cell cultures were treated in vitro with both SSA and RBC, the PFC response to RBC was generally higher than that obtained with RBC stimulation only, suggesting that the Shigella antigen exerted an adjuvant effect on cultures from both normal and Shigella-tolerant mice.
Cultures prepared from spleens of both tolerant and normal mice challenged in vivo with SSA formed more PFC to RBC following treatment in vitro with SSA. This enhancing activity for SSA on the response to RBC was best observed when both SSA and RBC were added in vitro on the initial day of culture to cell suspensions.
DISCUSSION
The results presented here confirm and extend previous studies, indicating that significant numbers of specific antibody-forming cells to Shigella antigen are not present in spleens of Shigellatolerant animals, as compared to normal controls (9) . In addition, previous studies had shown that serologically detectable antibody formation could not be induced in spleen cell cultures from tolerant animals, as occurred with similar cultures from normal animals (13) . However, in the previous in vitro experiments, antibody activity to Shigella was determined only by serological titrations of culture supernatant fluids or cell extracts.
It seems unlikely that the presence of antigen in cultures prepared from tolerant mouse spleens could interfere with detection of specific antibodyreleasing cells, as may occur with free antibody. Since significant numbers of plaques to SSA were not observed in spleen cultures from tolerant mice, it appears that continued unresponsiveness to SSA in vitro is on the cellular level. Such results indicate that tolerance to this antigen is not due to "masking" of immunocompetent cells by "excess" soluble antigen. If such were the case, lymphoid cells from tolerant animals maintained in vitro in an environment essentially free of such soluble antigen, especially after several changes of medium, might recover antibody-forming ability. No "escape" from tolerance was noted in these studies with tissue culture suspensions prepared from spleens of tolerant mice, with or without in vitro stimulation with SSA.
Antibody plaques to SSA-sensitized erythrocytes were detected in large numbers only with lymphoid cell suspensions from immunized control animals. There were only occasional "background" PFC in cultures prepared from normal mice that had not been challenged with SSA in (14, 19) .
The results presented here seem to be of direct relevance to the question of whether tolerance is related to central failure of the immune mechanism. There have been recent suggestions that some forms of immunological unresponsiveness could be related to a "feedback" inhibition due to specific humoral antibody (17, 18, 23 
